-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
- Vitro Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was -$149K, a 82.9% increase year-over-year.
- Vitro Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was -$9.76M, a 65.1% decline year-over-year.
- Vitro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.4M, a 21.3% increase from 2022.
- Vitro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$6.86M.
- Vitro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2015 was -$246K, a 0.27% increase from 2014.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)